Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Gaudio

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Diagnostics (Basel, Switzerland)|March 25, 2022
The Effect of the Tumor Microenvironment on Lymphoid Neoplasms Derived from B CellsGiuseppe Ingravallo, Roberto Tamma, Giuseppina Opinto, et al.
Current Oncology (Toronto, Ont.)|September 22, 2022
Diffuse Large B Cell Lymphoma Arising in Patients with Preexisting Hodgkin LymphomaEmilio Bellitti, Pierluigi Masciopinto, Pellegrino Musto, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 2, 2022
Indolent Lymphoproliferative T-Cell Disorders Associated With Gastrointestional Disease: Diagnostic Challenges and OutcomesPierluigi Masciopinto, Emilio Bellitti, Elena Arcuti, et al.
Acta Haematologica|October 10, 2018
Bone Involvement in Hodgkin's Lymphoma: Clinical Features and OutcomeFrancesco Gaudio, Pasquale Pedote, Artor Niccoli Asabella, et al.
Annals of Hematology|July 29, 2018
Brentuximab vedotin as salvage treatment in Hodgkin lymphoma naïve transplant patients or failing ASCT: the real life experience of Rete Ematologica Pugliese (REP)Vincenzo Pavone, Anna Mele, Daniela Carlino, et al.
Blood|August 6, 2011
BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patientsGiuseppe Visani, Lara Malerba, Pietro Maria Stefani, et al.
Journal of Occupational Medicine and Toxicology (London, England)|March 25, 2020
Correction to: Risk of lymphoma subtypes by occupational exposure in southern ItalyGiovanni Maria Ferri, Giorgina Specchia, Patrizio Mazza, et al.
Journal of Occupational Medicine and Toxicology (London, England)|December 5, 2017
Risk of lymphoma subtypes by occupational exposure in Southern ItalyGiovanni Maria Ferri, Giorgina Specchia, Patrizio Mazza, et al.
Frontiers in Oncology|August 29, 2025
Diagnostic and therapeutic pathways for lymphoma patients: expert consensus through Nominal Group Technique and Delphi methodologyAttilio Guarini, Valentina Bozzoli, Sabino Ciavarella, et al.
Annals of Hematology|January 16, 2023
A real-world analysis of PD1 blockade from the Rete Ematologica Pugliese (REP) in patients with relapse/refractory Hodgkin's lymphomaFrancesco Gaudio, Giacomo Loseto, Valentina Bozzoli, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Diagnostics (Basel, Switzerland)|March 25, 2022
The Effect of the Tumor Microenvironment on Lymphoid Neoplasms Derived from B CellsGiuseppe Ingravallo, Roberto Tamma, Giuseppina Opinto, et al.
Current Oncology (Toronto, Ont.)|September 22, 2022
Diffuse Large B Cell Lymphoma Arising in Patients with Preexisting Hodgkin LymphomaEmilio Bellitti, Pierluigi Masciopinto, Pellegrino Musto, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 2, 2022
Indolent Lymphoproliferative T-Cell Disorders Associated With Gastrointestional Disease: Diagnostic Challenges and OutcomesPierluigi Masciopinto, Emilio Bellitti, Elena Arcuti, et al.
Acta Haematologica|October 10, 2018
Bone Involvement in Hodgkin's Lymphoma: Clinical Features and OutcomeFrancesco Gaudio, Pasquale Pedote, Artor Niccoli Asabella, et al.
Annals of Hematology|July 29, 2018
Brentuximab vedotin as salvage treatment in Hodgkin lymphoma naïve transplant patients or failing ASCT: the real life experience of Rete Ematologica Pugliese (REP)Vincenzo Pavone, Anna Mele, Daniela Carlino, et al.
Blood|August 6, 2011
BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patientsGiuseppe Visani, Lara Malerba, Pietro Maria Stefani, et al.
Journal of Occupational Medicine and Toxicology (London, England)|March 25, 2020
Correction to: Risk of lymphoma subtypes by occupational exposure in southern ItalyGiovanni Maria Ferri, Giorgina Specchia, Patrizio Mazza, et al.
Journal of Occupational Medicine and Toxicology (London, England)|December 5, 2017
Risk of lymphoma subtypes by occupational exposure in Southern ItalyGiovanni Maria Ferri, Giorgina Specchia, Patrizio Mazza, et al.
Frontiers in Oncology|August 29, 2025
Diagnostic and therapeutic pathways for lymphoma patients: expert consensus through Nominal Group Technique and Delphi methodologyAttilio Guarini, Valentina Bozzoli, Sabino Ciavarella, et al.
Annals of Hematology|January 16, 2023
A real-world analysis of PD1 blockade from the Rete Ematologica Pugliese (REP) in patients with relapse/refractory Hodgkin's lymphomaFrancesco Gaudio, Giacomo Loseto, Valentina Bozzoli, et al.
Pageof 6